In sum, decitabine-mediated upregulation of CSPG4 on SKOV-3 ovarian cancer cells enables antigen-specific targeting using CSPG4-CAR-T cells resulting in effective CSPG4-directed target cell killing even in the presence of decitabine. Here, CSPG4 is linked to ovarian carcinoma.